Empagliflozin as treatment in glycogen storage disease type IB patients
Empagliflozin offers promising results in improving morbidity and quality of life in patients with GSD Ib, including the first double organ transplant patient treated with this drug.
Authors
- José Pablo Suárez Llanos (ORCID: https://orcid.org/0000-0002-7409-3196)
- Marina Gutiérrez Vilar
- Cristina Lorenzo González
- Elena Márquez Mesa
- L. Arhip (ORCID: https://orcid.org/0000-0003-4630-7844)
- Mónica Ruiz Pons
- M. Rodríguez (ORCID: https://orcid.org/0000-0002-6922-266X)
Institutions
- Hospital Universitario Nuestra Señora de Candelaria (ES)
- Nutricia Research (Netherlands) (NL)
Publication Details
- Journal
- Molecular Genetics and Metabolism Reports
- Published
- 2025-05-03
- DOI
- https://doi.org/10.1016/j.ymgmr.2025.101226
- Citations
- 1
- Primary Topic
- Glycogen Storage Diseases and Myoclonus
- Type
- article
- Field-Weighted Citation Impact
- 1.67